Welcome to Seesaw Vision Center

 Ortho-K lenses, also known as orthokeratology lenses, are considered effective in slowing down the progression of myopia (nearsightedness) in children, with studies showing a significant reduction in axial length elongation (eye growth) when compared to wearing regular glasses, achieving a myopia control efficacy ranging from 30% to 60% depending on the individual and lens design. 

 If your child has trouble seeing far away (nearsightedness, known as myopia), you can correct AND help protect their vision from getting worse as they grow! Meet MiSight® 1 day soft contact lenses specifically designed for myopia control and FDA approved* to slow the progression of myopia in children ages 8-12 at the initiation of treatment.

The ideal atropine concentration is effective in slowing both myopia progression and axial elongation while also mitigating the side effects of the drug. Systemic side effects can occur with higher concentrations, but with low-dose atropine the most common side effects are ocular. Glare, photophobia and rarely blurred near vision are the most common side effects. The LAMP study demonstrated that atropine 0.05% is similar in efficacy to optical treatments such as orthokeratology and soft multifocal contact lenses. However, the debate on the optimal concentration of atropine is still undecided and may differ by patient.

Low-dose atropine treatment for myopia is not approved by FDA yet. Doctors are working on it.

 Defocus eye glasses, also known as peripheral defocus lenses, are glasses that can help control myopia. They are designed to intentionally blur the peripheral vision while keeping central vision clear. This can help slow the progression of myopia in children and adolescents. Spectacle options such as MiYOSMART and Stellest aren't available in the U.S. yet,